+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

The new scope of condition-specific markers, NGS and genomics with advances in molecular diagnostics caters to need of rapid diagnostics, early detection and point-of-care testing. Various technological developments and advancements in in vitro diagnostics have led to a new variety of diagnostic tests, allowing patients to access novel treatments earlier.

After the success of inaugural congress held on 9th and 10th November 2016, MarketsandMarkets is organizing Infectious Diseases Diagnostics Conference to be held on February 21st  and 22nd , 2018 in London, UK, aims to bring different stakeholders together from hospitals, laboratories academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.

conference Registration Form



Solution Provider Delegate£999
Hospitals / Academia£349


Key Highlights

  • Developments in POCT diagnostics- Biomarkers and POCT in low resource setting
  • Optimization of diagnostic test to reduce the turnaround time for results
  • Molecular diagnostics and molecular assays  for infectious diseases
  • Rapid diagnosis using Multiplex Testing for multiple pathogen detection at a time
  • NGS in Infectious diseases
  • Genomic biomarkers for early detection
  • Challenges in Antimicrobial resistance testing
To get the agenda copy, kindly email us at events@marketsandmarkets.com

Who Should Attend ?

From Hospitals, Reference Laboratories, Research Institutes and Academics

Directors, head of laboratory, lab managers, deputy lab managers, chief/head biomedical scientist, laboratory technician, professors, associate professors, research fellow, POCT lead


  • Pathology
  • Molecular pathology
  • Biochemistry/ Clinical biochemistry
  • Microbiology/ Clinical Microbiology
  • Molecular Biology
  • Virology
  • Infectious diseases
  • Point of care testing

Why attend?

  • Find out new case studies of emerging methods of diagnostics in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in pathology
Share your work and achievements with your industry peers in the Poster Session


  • Dr Eric Claas

    Molecular Medical Microbiologist, Department of Medical Microbiology Leiden University Medical Center, Netherlands
  • Dr Ann Van den Bruel

    Director and Associate Professor, NIHR Diagnostic Evidence Cooperative Oxford University of Oxford, UK
  • Dr Jens Ducrée

    Professor and Director – Fraunhofer Project Centre for Embedded Bioanalytical Systems Biomedical Diagnostics Institute, Dublin City University, Ireland
  • Dr Virve (Vicky) Enne

    Co-ordinator for INHALE project and Sr Research Associate University College London, UK
  • Dr Giovanni Satta

    Consultant, medical microbiology and infectious diseases Imperial College Healthcare NHS Trust, UK
  • Prof A P R Wilson

    Consultant Microbiologist, Clinical Microbiology & Virology UCLH NHS Foundation Trust, UK
  • Dr Rogier Hopstaken

    General practitioner and Specialist, Point of care testing Saltro diagnostic centre, Maastricht University, Netherlands
  • Prof Dilip Nathwani

    Consultant Physician in Infectious Diseases, Honorary Professor of Infection and Co-Director, Tayside Academic Health Sciences Partnership, UK Ninewells Hospital and Medical School, UK
  • Dr. Husam Osman

    Clinical Service Director, Consultant Virologist, Public Health Laboratory, Birmingham Heartlands Hospital, UK University Hospital NHS Foundation Trust, Birmingham, UK
  • Dr Jaya Shrivastava

    Parasitology Scheme Manager, UK NEQAS Public Health England, UK
  • Prof. Dr. H.G.M. Niesters

    Professor, Medical Microbiology and Director, Laboratory of Clinical Virology University Medical Centre Groningen, The Netherlands
  • Rebecca Gorton

    Senior Health Care Scientist, Microbiology/Mycology, Health Services Laboratories, UK
  • Dr Tim Brooks

    Clinical Services Director, Rare & Imported Pathogens Public Health England, UK
  • Dr Emily Adams

    Diagnostic lead, Research Centre for Drugs and Diagnostics and Lecturer, Diagnostics for Infectious Disease Liverpool School of Tropical Medicine, UK
  • Dr Adriana Calderaro

    Associate Professor of Clinical Microbiology, University Hospital of Parma, Italy
  • Dr. Thomas Lion

    Professor and Medical Director Children’s Cancer Research Institute, Austria
  • Dr. Rangarajan Sampath

    Chief Scientific Officer FIND, Switzerland
  • Dr.Patrice Allibert

    CEO GenePOC Québec, QC
  • Prof Richard O Kennedy

    Professor of Biosciences- School of Biotechnology, Dublin City University, Dublin
  • Anita Sharma

    GP and Clinical Director Vascular Oldham CCG, NICE QSAC GP Member, South Chadderton Health Centre, UK
  • Richard O’Kennedy

    Vice-President for Research, HBKU
  • Prof. Zari Tehrani

    Professor, College of Engineering Swansea University, UK



fujifilm Fujifilm

is a pioneer in medical diagnostic imaging and information systems. The FUJI DRI-CHEM (FDC) system based on a multi-layered film method was first launched in 1984. Over 18,000 units have now been installed globally with various DRI-CHEM analysers and reagents having been developed to fulfil the increasing demand for automated Point of Care Testing. In 2017, FUJIFILM launched the FDC Immuno AG1 densitometry analyser, an innovative rapid diagnostic test system for infectious diseases


Located in Québec City, Canada, GenePOC Inc. develops, produces and commercializes easy-to-use molecular tests (GenePOC PIEs), to improve the diagnosis of infectious diseases at Point-of-Care. The GenePOC PIEs are single-use disposables to be used with the portable revogeneTM instrument. A unique microfluidic technology allows for the early detection of infectious diseases in less than 70 minutes. Today, GenePOC has launched a CE-IVD CDiff assay and CE-IVD and FDA cleared GBS assay. 

VH Bio 

VH Bio Ltd

VH Bio Ltd is a leading supply and distribution company for the life sciences industry within the United Kingdom and Republic of Ireland. We are jointly sponsoring and exhibiting at the Infectious Diseases Diagnostics Conference with our supply partner, Molzym, who are a manufacturer of novel and innovative products for molecular microbiology and diagnostics.Together, our product portfolio ranges from MolYsis™ pre-analytical kits for the enrichment of microbial DNA from whole blood and other body fluids to DNA-free PCR reagents, particularly for 16S/18S rRNA gene analysis.For routine in-vitro pathogen diagnosis, our culture-independent PCR-based SepsiTest-UMD and Micro-Dx™ kits combine MolYsis™ technology for microbial DNA isolation from blood, other body fluids, swabs and tissues with universal 16S/18S rDNA detection in one convenient kit.


Institut Virion\Serion is one of the leading manufacturers of infection serology ELISA diagnostics. We have developed more than 120 highly specific and sensitive test systems for serological detection of infectious diseases. Based on 40 years of experience in the manufacturing of high grade serological antigens we recently launched our new division SERION Immunologics, offering a wide range of highly purified native or recombinant bulk antigens to detect pathogen specific antibodies from viral, bacterial or fungal origins.

Hibergene HiberGene Diagnostics

HiberGene Diagnostics  develops, manufactures and markets diagnostic tests for infectious diseases using LAMP (loop-mediated isothermal amplification) technology.
HiberGene is committed to providing rapid, accurate and reliable testing solutions. Current tests on the market include HG Meningococcus, HG Group B Streptococcus, HG C. difficile and HG Mycoplasma pneumoniae. Tests for HG Meningococcus/Pneumococcus, HG RSV A/B and HG Flu A/B will be released in coming months.


Anvajo is Health Tech company based in Germany, which spun off the Dresden University of Technology. In several years of scientific research, a blood testing device has been developed providing immediate results at lab-grade accuracy with only 1 drop of blood to analyze cell characteristics, biomarkers and pathogens. The first available test focuses on the diagnostics of infectious diseases to minimize unnecessary prescription of antibiotics.



"Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. 
Roche’s Point of Care portfolio is always growing and includes comprehensive IT and Managed Service solutions. To find out more about how Roche can meet your POC testing needs, please go to www.roche.co.uk or visit our stand."



Molzym is a manufacturer of innovative products for molecular microbiology and diagnostics. The product portfolio ranges from proprietary DNA isolation kits to ultra-clean, DNA-free PCR reagents and 16S/18S rDNA assays.The MolYsis™ technology allows the enrichment of microbial DNA from fluid and tissue samples for PCR and NGS applications for the precise analysis of pathogens and microbial communities.CE-IVD marked manual and automated solutions, SepsiTest-UMD and Micro-Dx
, are supplied for the culture-independent routine pathogen diagnosis. 



Curetisis a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. Its diagnostic solution Unyvero enables rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. Curetis is headquartered in Holzgerlingen, Germany.

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-One Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com


All Poster presentations will take place in breaks and alongside the breakout sessions of thecongress. All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:
Email: events@marketsandmarkets.com

Posters Submission Form



Bio partner supporting associationBioPartner

BioPartner is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartnership Programme, members receive extra benefits and support to effectively trade overseas.

irish decontamination institute Irish Decontamination Institute

The Irish Association of Sterile Services Managers was established in 1989, changed its name to 
Irish Decontamination Institute in January 2011. Its aim is to ensure its members are up to date with developments in sterile services and to network this information to hospital sterile service departments throughout Ireland. It continues to fulfil this aim by spearheading a revolution in sterilization thought, the organizing of conferences and study days, and the dissemination of information in decontamination and sterilization. Currently, it has representation on the board of the World Forum for Hospital Sterile Supply (WFHSS) and the World Federation and was founding member of the EFHSS.

The IDI has been acknowledged nationally and internationally as a leading organization associated with decontamination and sterilization. Nationally, the IDI continues to promote education in decontamination and sterilization through its involvement with the Institute of Technology, Tallaght course set up in 2000. Internationally, in 2002 the IDI was given the honour of hosting the EFHSS Conference 2002 which was attended by over 300 delegates world wide, and proved to be a great success. Many local and international speakers are now world experts in decontamination and sterilization.

With the advent of new medical device technology and increasing demands from sterile service departments, it is becoming more important that the IDI continues to grow nationally and internationally to meet the ever increasing challenges.


MEDEC is the national association representing the medical technology industry in Canada. Our members are committed to providing safe and innovative medical technologies that enhance patient care and advance patient outcomes. The medical technology industry in Canada employs over 35,000 Canadians in close to 1,500 corporate facilities, and has sales of nearly $7 billion per annum. We are committed to ensuring that Canada has a strong and vibrant medical technology industry.


Infectious Diseases Diagnostics Conference will be held at the Thistle London Heathrow Terminal 5 in London, UK.

Thistle London Heathrow Terminal 5
Bath Road, Longford
London UB7 0EQ 
Hotel:  +44 (0) 800 330 8086 / +44 (0) 20 8624 4010 

Hotel Booking Link

Accommodation is currently available at the Thistle London Heathrow Terminal 5 at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us.

About the Hotel

Thistle London Heathrow Terminal 5 is the perfect choice if you’re flying early, landing late or just want the holiday to last a little longer. As well as being handy for all the terminals at London Heathrow, we’re located close to the A4 and M25, making Thistle London Heathrow Terminal 5 the ideal base for visits to the nearby Windsor Castle, Kew Gardens and Wembley Stadium.

For further information, please contact:
Email: events@marketsandmarkets.com